2D Graphene & MXene Single-Cell Immunotoxicity Reference

3-Descriptor Structure-Toxicity Relationship · CyTOF / scRNA-seq Profiling & Pyrogen Decoupling

Synthesized from Graphene Flagship Safety Frameworks, PubMed Central Space & Tissue Immunity Reviews, and ISO 29701.

1. Three-Descriptor Classification & Immune Thresholds

Reporting 2D carbon materials solely by supplier catalog name or mass concentration obscures the physical drivers of innate immune activation. Because lateral flake width determines macrophage membrane wrapping mechanics while oxygen functional groups govern protein corona composition and aqueous dispersibility, translational dossiers lock all three Graphene Flagship descriptors prior to EUNCL-ITA immune panels.

In primary human peripheral blood mononuclear cells (PBMCs) evaluated via mass cytometry (CyTOF) and single-cell RNA sequencing, thin carboxylated or hydroxylated graphene oxide sheets below 400 nm lateral diameter induce minimal monocyte apoptosis at doses under 10 cm2/mL BET surface area. By contrast, laterally large sheets (> 1,000 nm) or hydrophobic reduced graphene oxide (rGO) sheets with C:O ratios exceeding 8.0 promote prolonged membrane contact, reactive oxygen species bursts, and pro-inflammatory M1 macrophage polarization. Surface functionalization with biocompatible polyethylene glycol (PEG) or dextran mitigates non-specific complement C3b adsorption, though investigators must still screen anti-PEG antibodies using NCI-NCL complement cascades.

2. Single-Cell Macrophage, Dendritic & T-Cell Response Axis

Bulk viability dyes such as MTT and CCK-8 frequently misreport 2D nanomaterial cytotoxicity because graphene nanosheets catalyze formazan crystal formation or adsorb dye directly onto basal sp2 domains. Replacing bulk optical viability tests with single-cell multiparametric flow cytometry or CyTOF resolves cell-subset-specific toxicity across CD14+ classical monocytes, CD16+ non-classical monocytes, plasmacytoid dendritic cells, and CD4+/CD8+ T-cell compartments within the same donor PBMC sample.

High-dimensional single-cell studies demonstrate that monocytes and macrophages internalize up to ten-fold more 2D material per cell than resting lymphocytes. Consequently, apparent T-cell suppression in bulk culture is often an indirect consequence of monocyte cytokine release or antigen-presenting dendritic cell exhaustion rather than direct lymphocytic lysis. Testing purified T-cell populations alongside whole-PBMC co-cultures separates direct cytotoxicity from myeloid-driven paracrine signaling, while maintaining strict 10.0 cm2/mL BET surface-area dose ceilings in our interactive dose workbench prevents physical smothering artifacts in adherent macrophage monolayers.

3. Inline Endotoxin Interference Diagnostic for 2D Flakes

Select your 2D dispersion status below to verify whether chromogenic LAL results are analytically valid or masked by basal-plane adsorption.

4. Comparative Stability: Graphene Oxide vs. Ti3C2Tx MXene

Transition-metal carbides and nitrides (MXenes, predominantly Ti3C2Tx) share 2D sheet morphology with graphene oxide but undergo progressive aqueous oxidation into titanium dioxide nanoparticles and dissolved fluoride/titanium species when stored without argon purging or antioxidant stabilization. Consequently, aged MXene dispersions exhibit time-dependent shifts in hydrodynamic diameter, zeta potential, and macrophage oxidative stress that do not occur in chemically stable graphene oxide stocks.

Preclinical teams bridging 2D materials into implantable scaffolds or wound-monitoring electrodes should cross-check dispersion shelf-life against hydrogel scaffold phase gates and run ISO 10993-12 extractables testing on oxidized batches. Never pool immunotoxicity replicates from fresh (< 48 h) and aged (> 14 d) MXene suspensions without re-measuring Raman spectra and surface oxygen stoichiometry.

5. Primary Human PBMC Single-Cell & Cytokine Profiling SOP

When transitioning from acellular endotoxin and complement screening to cellular immune profiling, immortalized monocytic cell lines (such as THP-1 or RAW 264.7) frequently under-report plasmacytoid dendritic cell, NK-cell, and primary T-cell activation signatures triggered by few-layer graphene and oxidized MXene sheets. Preclinical characterization packages aligned with European Safe-by-Design expectations pair fresh primary human peripheral blood mononuclear cells (PBMCs) from at least three healthy donors (seronegative, resting baseline IL-6 < 5 pg/mL) with orthogonal endotoxin verification.

Suspensions are dosed across a logarithmic concentration span (typically 1, 5, 25, and 50 ug/mL, normalized simultaneously to BET surface area in cm2/mL) for 24 hours in endotoxin-certified RPMI-1640 supplemented with 10% heat-inactivated autologous or pooled human AB serum. Including a parallel condition with polymyxin B sulfate (10 ug/mL) isolates intrinsic 2D material inflammasome activation (NLRP3/IL-1beta and TNF-alpha secretion) from trace lipopolysaccharide contamination adsorbed onto hydrophobic basal planes.

Flow cytometry or mass cytometry (CyTOF) panels should avoid fluorophores whose excitation/emission wavelengths overlap strongly with graphene light scattering or autofluorescence artifacts; include cell-free particle-only compensation controls in every acquisition run. Quantitative release criteria require reporting cell viability (7-AAD or Annexin V/PI), monocyte CD14/CD86 co-stimulatory upregulation, and multiplex cytokine fold-change relative to vehicle and LPS (100 ng/mL) positive controls. For batch release remediation when dispersion viscosity or lateral size exceeds target windows, consult the Safe-by-Design Stage Gate.